We are glad to announce that we have secured investment from Genesis Ventures. This pre-seed funding round…
Averywell Secures Genesis Ventures Investment: Pioneering Lung Cancer Detection with MiRNA Tech
read more
News & Blogs
The UK Lung Screening Programme: A Step Forward in Early Detection
Recognising the critical importance of early detection, the NHS has initiated a pioneering lung screening programme…
Who should get a CT Scan?
Currently, several models are used to pre-screen patients for lung cancer and to determine eligibility for CT scans. However, most of these models are designed specifically for smokers…
Lung Cancer Among People Who Never Smoked
In the UK, experts say that 1 in 6 people dying of lying cancer are non-smokers.
Lung Cancer is notoriously known as a ‘Smoker’s Disease’.
Recognition By Cancer Research Horizons
We are happy to share that we have been recognised by Cancer Research Horizons during the 2024 Innovation & Entrepreneurship Awards!
Finalist at 2023 BioCap Conference
We are happy to share that Averywell was listed as a finalist at the 2023 BioCap Conference held by Bionow.
Bionow is a non-profit hoping to support the biomedical, pharma and life sciences sectors across North England.
Manchester start-up set to launch clinical trials for lung cancer detection
Manchester MedTech company Averywell is set to start UK clinical trials on a ground breaking early detection test for lung cancer later this year. Averywell has developed a proprietary technology
Averywell wins Medtech & Healthtech StartUp of the Year – 2023 North West StartUp Awards
We are pleased to share that Averywell was crowned the winner in the 2023 North West StartUp Awards as the Medtech & Healthtech StartUp of the Year. “The...
Averywell Selected for Prestigious Global Entrepreneur Programme: Game-Changer for Innovation and Growth
We, at Averywell, are thrilled to announce…